PPC Letter Triggers Investigation into NextSource Biotechnology

 

For Immediate Release

From: The Board of the People's Progressive Caucus of Miami-Dade
Media contact: William Byatt - (305) 900-8648 - william.byatt@miamiprogressives.org

PPC Letter Triggers State Attorney Gouging Investigation Into NextSource Biotechnology

The office of State Attorney Katherine Fernandez Rundle has assigned an investigator to NextSource Biotechnology to determine if their 1400% price increases for cancer drug Gleostine constitutes gouging under Florida Statutes. Several of NextSource's predatory price hikes occurred during periods that may have exploited emergency conditions created by last year's Hurricane Irma.

This investigation follows an open letter published by the Board of the PPC on January 1, 2018 calling on local elected officials and candidates to fight for policy that will curtail these toxic business practices. In response to that letter, City of Miami Commissioner requested that the State Attorney's office open an investigation. On Saturday, January 29, at a fundraiser event for the Miami-Dade Young Democrats, Commissioner Russell confirmed that the State Attorney has responded to his request by opening an investigation.